The Hydration Pharmaceuticals Co (ASX:HPC) Accounts Payable & Accrued Expense: A$0.46 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is The Hydration Pharmaceuticals Co Accounts Payable & Accrued Expense?

The Hydration Pharmaceuticals Co ASX:HPC Accounts Payable & Accrued Expense is A$0.46 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

The Hydration Pharmaceuticals Co's quarterly accounts payable & accrued expense declined from Jun. 2025 (A$1.12 Mil) to Dec. 2025 (A$0.53 Mil) and declined from Dec. 2025 (A$0.53 Mil) to Jun. 2026 (A$0.46 Mil).

The Hydration Pharmaceuticals Co's annual accounts payable & accrued expense declined from Dec. 2023 (A$3.96 Mil) to Dec. 2024 (A$2.35 Mil) and declined from Dec. 2024 (A$2.35 Mil) to Dec. 2025 (A$0.53 Mil).

The Hydration Pharmaceuticals Co Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Accounts Payable & Accrued Expense Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
2.19 2.98 3.96 2.35 0.53

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25 Dec25 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only 3.96 4.61 1.12 0.53 0.46

The Hydration Pharmaceuticals Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of A$0.46 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Accounts Payable & Accrued Expense of A$0.46 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Accounts Payable & Accrued Expense too high?
The Hydration Pharmaceuticals Co's current Accounts Payable & Accrued Expense is A$0.46 Mil.
How does The Hydration Pharmaceuticals Co's Accounts Payable & Accrued Expense compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Accounts Payable & Accrued Expense of A$0.46 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Retail - Defensive company?
A good Accounts Payable & Accrued Expense depends on the Retail - Defensive industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Accounts Payable & Accrued Expense is A$0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Accounts Payable & Accrued Expense of A$0.46 Mil. The current Accounts Payable & Accrued Expense is A$0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Accounts Payable & Accrued Expense is A$0.46 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.